Purgo Scientific

About

Purgo Scientific, Inc. is advancing localized therapeutic delivery through innovative drug-device technology designed to deliver medication precisely where it is needed most. Our initial focus is addressing biofilm-related surgical site infections associated with indwelling medical devices, including orthopedic implants—an under-served clinical challenge affecting up to 300,000 patients annually in the United States and costing the healthcare system as much as $10 billion each year. By enabling high-concentration, site-specific antibiotic delivery, Purgo's approach is designed to overcome the limitations of systemic therapies and improve infection control while reducing overall treatment burden. Beyond infection management, Purgo is developing a versatile platform with the potential to support a wide range of applications where precise, localized drug delivery can improve outcomes, including pain management, oncology, and other targeted therapeutic areas.